Skip to main content
SpringerLink
Log in

Pediatric Ocular Surface Disease

  • Chapter
  • First Online:
Ocular Surface Disease

  • 867 Accesses

Abstract

Pediatric ocular surface disease can lead to significant morbidity and loss of vision that has the potential to become “permanent” due to amblyopia. Therefore, aggressive management is warranted especially in the amblyopic age group. Phlyctenulosis or blepharokeratoconjunctivitis is perhaps the most common pediatric ocular surface condition that can lead to stromal scarring and significant vision loss. As highlighted in case 1, an effective management strategy involves lid hygiene, long-term oral azithromycin, and topical anti-inflammatory therapy (steroids tapered to cyclosporine/tacrolimus). Cases 2 and 3 similarly describe two pediatric patients with ocular surface disease and their effective management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Souza PM, Holland EJ, Huang AJ. Bilateral herpetic keratoconjunctivitis. Ophthalmology. 2003;110(3):493–6.

    Article  PubMed  Google Scholar 

  2. Bonini S, Coassin M, Aronni S, Lambiase A. Vernal keratoconjunctivitis. Eye. 2004;18:345–51.

    Article  CAS  PubMed  Google Scholar 

  3. Hammersmith KM. Blepharokeratoconjunctivitis in children. Curr Opin Ophthalmol. 2015;26(4):301–5.

    Article  PubMed  Google Scholar 

  4. Hammersmith KM, Cohen EJ, Blake TD, Laibson PR, Rapuano CJ. Blepharokeratoconjunctivitis in children. Arch Ophthalmol. 2005;123(12):1667–70.

    Article  PubMed  Google Scholar 

  5. Ianaro A, Ialenti A, Maffia P, Sautebin L, Rombola L, Carnuccio R, et al. Anti-inflammatory activity of macrolides antibiotics. J Pharmacol Exp Ther. 2000;292(1):156–63.

    CAS  PubMed  Google Scholar 

  6. Cetinkaya A, Akova YA. Pediatric ocular rosacea: long-term treatment with systemic antibiotics. Am J Ophthalmol. 2006;142(5):816–21.

    Article  CAS  PubMed  Google Scholar 

  7. Kwok AK, Lam DS, Fan DS, et al. Ocular hypertensive response to topical steroids in children. Ophthalmology. 1997;104(12):2112–6.

    Article  CAS  PubMed  Google Scholar 

  8. Huang C, O’Hara M, Mannis MJ. Primary pediatric keratoplasty: indications and outcomes. Cornea. 2009;28(9):1003–8.

    Article  PubMed  Google Scholar 

  9. Thomas PB, et al. Long term cyclosporine treatment improves tear production and reduces keratoconjunctivitis in rabbits with induced autoimmune dacryoadenitis. J Ocul Pharmacol Ther. 2009;25(3):285–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Doan S, Gabison E, Gatinel D, et al. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis. Am J Ophthalmol. 2006;141:62–6.

    Article  CAS  PubMed  Google Scholar 

  11. Choi DS, Djalilian A. Oral azithromycin combined with topical anti-inflammatory agents for the treatment of blepharokeratoconjunctivitis in children. J AAPOS. 2013;17(1):112–3. Epub 2013 Jan 27

    Article  PubMed  PubMed Central  Google Scholar 

  12. Doan S, Gabison E, Chiambaretta F, Touati M, Cochereau I. Efficacy of azithromycin 1.5% eye drops in childhood ocular rosacea with phlyctenular blepharokeratoconjunctivitis. J Ophthalmic Inflamm Infect. 2013;3(1):38.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kymionis GD, Kankariya VP, Kontadakis GA. Tacrolimus ointment 0.03% for the treatment of refractory childhood phlyctenular keratoconjunctivitis. Cornea. 2012;31:950–2.

    Article  PubMed  Google Scholar 

  14. Gupta N, Dhawan A, Beri S, D’souza P. Clinical spectrum of pediatric blepharokeratoconjunctivitis. J AAPOS. 2010;14(6):527–9. Epub 2010 Nov 19

    Article  PubMed  Google Scholar 

  15. Liang L, Safran S, Gao Y, Sheha H, Raju VK, Tseng SC. Ocular demodicosis as a potential cause of pediatric blepharoconjunctivitis. Cornea. 2010;29(12):1386–91.

    Article  PubMed  Google Scholar 

  16. Doan S, Gabison EE, Nghiem-Buffet S, Abitbol O, Gatinel D, Hoang-Xuan T. Long-term visual outcome of childhood blepharokeratoconjunctivitis. Am J Ophthalmol. 2007;143(3):528–9. Epub 2006 Nov 9

    Article  PubMed  Google Scholar 

  17. Jones SM, Weinstein JM, Cumberland P, Klein N, Nischal KK. Visual outcome and corneal changes in children with chronic blepharoconjunctivitis. Ophthalmology. 2007;114(12):2271–80.

    Article  PubMed  Google Scholar 

  18. Kallish S, McDonald-McGinn DM, van Haelst MM, Bartlett SP, Katowitz JA, Zackai EH. Ablepharon–Macrostomia syndrome—extension of the phenotype. Am J Med Genet A. 2011;155:3060–2.

    Article  Google Scholar 

  19. Stevens CA, Sargent LA. Ablepharon-Macrostomia syndrome. Am J Med Genet. 2002;107:30–7.

    Article  PubMed  Google Scholar 

  20. Jackson IT, Shaw KE, del Pinal Matorras F. A new feature of the ablepharon macrostomia syndrome: zygomatic arch absence. Br J Plast Surg. 1988;41:410–6.

    Article  CAS  PubMed  Google Scholar 

  21. McCarthy GT, West CM. Ablepheron (sic) macrostomia syndrome. Dev Med Child Neurol. 1977;19:659–72.

    Article  CAS  PubMed  Google Scholar 

  22. Price NJ, Pugh RE, Farndon PA, Willshaw HE. Ablepharon Macrostomia syndrome. Br J Ophthalmol. 1991;75:317–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Murthy R, Gupta H. Novel surgical technique for the management of partial cryptophthalmos. Indian J Ophthalmol. 2014;62(11):1096–8.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Cruz AA, Souza CA, Ferraz VE, Monteiro CA, Martins FA. Familial occurrence of ablepharon macrostomia syndrome: eyelid structure and surgical considerations. Arch Ophthalmol. 2000;118:428–30.

    CAS  PubMed  Google Scholar 

  25. Ferraz VE, Melo DG, Hansing SE, Cruz AA, PinaNeto JM. Ablepharon-Macrostomia syndrome: first report of familial occurrence. Am J Med Genet. 2000;94:281–3.

    Article  CAS  PubMed  Google Scholar 

  26. Marchegiani S, Taylor D, Tessadori F, et al. Recurrent mutation sin the basic domain of TWIST2 cause Ablepharon Macrostomia and Barber-Say syndromes. Am J Hum Genet. 2015;97:99–110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Mustard JC. Reconstruction of both lids. In: Mustarde JC, editor. Repair and reconstruction in the orbital region. A practical guide. 2nd ed. London: Churchill Livingstone; 1980. p. 152–4.

    Google Scholar 

  28. Hay D. Reconstruction of both eyelids following traumatic loss. Br J Plast Surg. 1971;24:361–4.

    Article  CAS  PubMed  Google Scholar 

  29. Kim M, Lee S-C, Lee S-J. Spontaneous corneal perforation in an eye with Peters’ anomaly. Clin Ophthalmol. 2013;7:1535–7.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Liesegang TJ, Melton LJ, Daly PJ, Ilstrup DM. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol. 1989;107(8):1155–9.

    Article  CAS  PubMed  Google Scholar 

  31. Hill JM, Ball MJ, Neumann DM, Azcuy AM, Bhattacharjee PS, Bouhanik S, et al. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J Virol. 2008;82(16):8230–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964–73.

    Article  CAS  PubMed  Google Scholar 

  33. Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2—United States, 1999–2010. J Infect Dis. 2014;209(3):325–33.

    Article  PubMed  Google Scholar 

  34. Darougar S, Wishart MS, Viswalingam ND. Epidemiological and clinical features of primary herpes simplex virus ocular infection. Br J Ophthalmol. 1985;69(1):2–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Wishart MS, Darougar S, Viswalingam ND. Recurrent herpes simplex virus ocular infection: epidemiological and clinical features. Br J Ophthalmol. 1987;71(9):669–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Beigi B, Algawi K, Foley-Nolan A, O’Keefe M. Herpes simplex keratitis in children. Br J Ophthalmol. 1994;78(6):458–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Hsiao C-H, Yeung L, Yeh L-K, Kao L-Y, Tan H-Y, Wang N-K, et al. Pediatric herpes simplex virus keratitis. Cornea. 2009;28(3):249–53.

    Article  PubMed  Google Scholar 

  38. Liu S, Pavan-Langston D, Colby KA. Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes. Ophthalmology. 2012;119(10):2003–8.

    Article  PubMed  Google Scholar 

  39. Herpetic Eye Disease Study Group (HEDS). Predictors of recurrent herpes simplex virus keratitis. Herpetic eye disease study group. Cornea. 2001;20(2):123–8.

    Article  Google Scholar 

  40. Chong E-M, Wilhelmus KR, Matoba AY, Jones DB, Coats DK, Paysse EA. Herpes simplex virus keratitis in children. Am J Ophthalmol. 2004;138(3):474–5.

    Article  PubMed  Google Scholar 

  41. Poirier RH. Herpetic ocular infections of childhood. Arch Ophthalmol. 1980;98(4):704–6.

    Article  CAS  PubMed  Google Scholar 

  42. Prabriputaloong T, Margolis TP, Lietman TM, Wong IG, Mather R, Gritz DC. Atopic disease and herpes simplex eye disease: a population-based case-control study. Am J Ophthalmol. 2006;142(5):745–9.

    Article  PubMed  Google Scholar 

  43. Wilhelmus KR, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, et al. Herpetic eye disease study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994;101(12):1883–1895; discussion 1895–6.

    Google Scholar 

  44. Barron BA, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, et al. Herpetic eye disease study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12):1871–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Illinois Hospital, Chicago, IL, USA

    Aisha Traish MD

Authors
  1. Aisha Traish MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aisha Traish MD .

Editor information

Editors and Affiliations

  1. Cornea Service, Illinois Eye and Ear Infirmary, Chicago, Illinois, USA

    Ali R. Djalilian

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Traish, A. (2018). Pediatric Ocular Surface Disease. In: Djalilian, A. (eds) Ocular Surface Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-15823-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15823-5_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15822-8

  • Online ISBN: 978-3-319-15823-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation